• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. WEB; INTRASACCULAR FLOW DISRUPTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. WEB; INTRASACCULAR FLOW DISRUPTION DEVICE Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aneurysm (1708); Stroke/CVA (1770); Perforation (2001); Thromboembolism (2654); Vascular Dissection (3160)
Event Type  Injury  
Manufacturer Narrative
The device lot numbers are unknown; therefore, a search for non-conformances associated with the actual part/lot number combinations could not be performed.The devices were implanted in the patient and not returned to the manufacturer for analysis.Additionally, procedural images were not provided; therefore, the reported event cannot be confirmed.The instructions for use identify thromboemboli, device migration, vessel dissection, and neurological deficits as potential complications associated with use of the device.
 
Event Description
As reported through the article titled, "influence of operator experience on the technical and clinical results of woven endobridge endovascular treatment for intracranial aneurysms" web-related complications occurred in 28 patients that underwent web treatment for an intracranial aneurysm from (b)(6) 2014 to (b)(6) 2020.The most common complication was thrombo-embolism (n = 19); while the other complications were as follows: rebleeding (n=2), artery dissection (n=2), perforation (n=1) and web migration (n=1).For seven patients, complications were associated with new-onset neurological deficits, which were transient in four cases and persistent in three.Complications were intraprocedural in nine patients (seven thrombo-embolic events, one perforation and one dissection).Additionally, there were 25 occurrences of raymond-roy 3 aneurysm remnant occlusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WEB
Type of Device
INTRASACCULAR FLOW DISRUPTION DEVICE
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key12510966
MDR Text Key272972414
Report Number2032493-2021-00385
Device Sequence Number1
Product Code OPR
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P170032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 08/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Disability;
-
-